We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ARDX icon
476
CALL
Ardelyx
ARDX
$847M
$46.3K ﹤0.01%
+150,000
New +$585K
2023 Q3
0 quarters
STWD icon
477
PUT
Starwood Property Trust
STWD
$4.7B
$41.3K ﹤0.01%
101,200
– –
2021 Q2
9 quarters
RLAY icon
478
CALL
Relay Therapeutics
RLAY
$3.92B
$40K ﹤0.01%
+80,000
New +$860K
2023 Q3
0 quarters
GAQ.WS icon
479
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$37.4K ﹤0.01%
938,800
– –
2023 Q2
1 quarter
RDN icon
480
PUT
Radian Group
RDN
$4.49B
$34.3K ﹤0.01%
54,900
– –
2021 Q2
9 quarters
FUBO icon
481
CALL
FuboTV Inc
FUBO
$267M
$32K ﹤0.01%
8,333
– –
2023 Q1
2 quarters
ANNX icon
482
CALL
Annexon
ANNX
$762M
$30K ﹤0.01%
300,000
-50,000
-14% -$151K
2023 Q2
1 quarter
NVO icon
483
CALL
Novo Nordisk
NVO
$171B
$30K ﹤0.01%
+20,000
New +$1.76M
2023 Q3
0 quarters
DISH
484
CALL
DELISTED
DISH Network Corp.
DISH
$29.5K ﹤0.01%
100,000
– –
2023 Q1
2 quarters
QURE icon
485
CALL
uniQure
QURE
$1.57B
$29.3K ﹤0.01%
90,000
+51,000
+131% +$459K
2023 Q2
1 quarter
HLT icon
486
PUT
Hilton Worldwide
HLT
$73.5B
$27.3K ﹤0.01%
14,000
– –
2022 Q1
6 quarters
XLV icon
487
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$26K ﹤0.01%
80,000
-20,000
-20% -$2.66M
2023 Q1
2 quarters
RMGCW icon
488
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$25.8K ﹤0.01%
184,086
– –
2021 Q2
9 quarters
INKT icon
489
MiNK Therapeutics
INKT
$54.7M
$25.3K ﹤0.01%
2,159
– –
2023 Q2
1 quarter
DCPH icon
490
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$25.3K ﹤0.01%
+50,000
New +$690K
2023 Q3
0 quarters
OMF icon
491
PUT
OneMain Financial
OMF
$6.45B
$24.6K ﹤0.01%
20,100
– –
2022 Q3
4 quarters
SPECW icon
492
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$23.2K ﹤0.01%
231,101
– –
2022 Q1
6 quarters
ALNY icon
493
CALL
Alnylam Pharmaceuticals
ALNY
$31.1B
$21.3K ﹤0.01%
+14,000
New +$2.67M
2023 Q3
0 quarters
MCAAW icon
494
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$20.5K ﹤0.01%
136,155
– –
2022 Q1
6 quarters
NVCR icon
495
CALL
NovoCure
NVCR
$1.7B
$19.4K ﹤0.01%
25,000
+3,000
+14% +$86.5K
2023 Q2
1 quarter
AEON.WS icon
496
DELISTED
AEON Biopharma Inc
AEON.WS
$17.4K ﹤0.01%
108,918
– –
2021 Q2
9 quarters
TRONW icon
497
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$16.4K ﹤0.01%
116,665
– –
2021 Q3
8 quarters
PRPC.WS
498
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$15.1K ﹤0.01%
73,635
– –
2022 Q1
6 quarters
OMF icon
499
CALL
OneMain Financial
OMF
$6.45B
$14.6K ﹤0.01%
+32,500
New +$1.39M
2023 Q3
0 quarters
CCVI.WS
500
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$14.3K ﹤0.01%
92,080
– –
2022 Q1
6 quarters
18 19
20
21 22

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.